Designing and Operating Flexible, High-Containment Vaccine Manufacturing

A new facility type integrates next-generation mobile cleanroom systems.

Facilities for advanced therapies should be configurable to flexibly segregate production for late-stage and commercial multiproduct operation. Efficient design of a flexible and high-containment vaccine manufacturing facility that can meet all the challenges presented by the market requires a design philosophy that includes all the key control concepts: air, people, equipment, product, and liquid and solid waste. This article discusses best practices for such control and describes the use of modular, mobile cleanrooms.

Download

Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017

eBook.

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 26–30

Citation

When referring to this article, please cite it as T. Page, "Designing and Operating Flexible, High-Containment Vaccine Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

Articles in this issue

almost 8 years ago

Article

Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases

almost 8 years ago

Article

Cold Chain: Delivering Vaccines to Patients

almost 8 years ago

Article

Using Human Challenge Trials to Develop Flu Vaccines

almost 8 years ago

Article

Moving to Closed Systems for Aseptic Processing

almost 8 years ago

Article

Making Vaccines Accessible

almost 8 years ago

Article

Accelerating Vaccine Development and Manufacturing

almost 8 years ago

Article

Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!